Proactive Investors AustraliaDr Kelly will be a member of Cynata s executive management team and will lead the regulatory, pre-clinical and clinical development of the company s proprietary Cymerus stem cell product pipeline. Dr. Kelly most recently served as Senior Director for read more
http://blog.zandcell.com/cynata-therapeutics-snares-former-astrazeneca-project-manager-to-advance-proactive-investors-australia/?utm_source=rss&utm_medium=rss&utm_campaign=cynata-therapeutics-snares-former-astrazeneca-project-manager-to-advance-proactive-investors-australia
Inga kommentarer:
Skicka en kommentar